The goal of these studies is to determine the mechanisms utilized by mouse neutrophils to control helminth infections. Previous studies have demonstrated that neutrophils are required for killing larval Strongyloides stercoralis in na?ve and immunized mice. The proposed studies will determine the molecular mechanisms used by neutrophils to kill the worm and methods used by antibody to accelerate parasite killing by neutrophils. These studies will provide an in depth analysis of how neutrophils control extracellular pathogens, and the findings will have applicability to our understanding of granulocyte control of bacterial, fungal and parasitic infections. The objective of Specific Aim 1 is to develop a comprehensive, sequential understanding of how mouse neutrophils kill the worms in the absence of antibody. It is clear from our previous studies that optimal neutrophil killing of the larvae results only after stimulation of the neutrophils with factors derived from macrophages and vice versa. We will decipher how neutrophils interact with macrophage derived factors to kill the parasites. The mechanisms and molecules used by the neutrophils to trap and then kill these non-phagocytosable pathogens will be determined.
In Specific Aim 2 we will determine how larval killing by neutrophils is accelerated and amplified by the presence of parasite-specific antibody. It will be determined if the increase in efficiency of immune killing of parasites by neutrophils is dependent on direct interaction between antibody and neutrophils or by an effect of antibody on the behavior of the parasites promoting killing by neutrophils.

Public Health Relevance

This grant is a comprehensive assessment of the mechanisms used by neutrophils to control worm infections. Studies in mice will provide the direction for future studies on the human antibody and cellular response to the human pathogen Strongyloides stercoralis. This proposal has the potential of leading to new vaccine approaches and therapies for strongyloidiasis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI076345-01A2
Application #
7885776
Study Section
Pathogenic Eukaryotes Study Section (PTHE)
Program Officer
Palker, Thomas J
Project Start
2009-08-01
Project End
2011-12-31
Budget Start
2009-08-01
Budget End
2011-12-31
Support Year
1
Fiscal Year
2009
Total Cost
$386,250
Indirect Cost
Name
Thomas Jefferson University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Bonne-Année, Sandra; Kerepesi, Laura A; Hess, Jessica A et al. (2014) Extracellular traps are associated with human and mouse neutrophil and macrophage mediated killing of larval Strongyloides stercoralis. Microbes Infect 16:502-11
Bonne-Année, Sandra; Kerepesi, Laura A; Hess, Jessica A et al. (2013) Human and mouse macrophages collaborate with neutrophils to kill larval Strongyloides stercoralis. Infect Immun 81:3346-55
Colombo, Matthew J; Abraham, David; Shibuya, Akira et al. (2011) B1b lymphocyte-derived antibodies control Borrelia hermsii independent of Fc?/? receptor and in the absence of host cell contact. Immunol Res 51:249-56
Bonne-Année, Sandra; Hess, Jessica A; Abraham, David (2011) Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model. Immunol Res 51:205-14
O'Connell, Amy E; Hess, Jessica A; Santiago, Gilberto A et al. (2011) Major basic protein from eosinophils and myeloperoxidase from neutrophils are required for protective immunity to Strongyloides stercoralis in mice. Infect Immun 79:2770-8
O'Connell, Amy E; Redding, Kevin M; Hess, Jessica A et al. (2011) Soluble extract from the nematode Strongyloides stercoralis induces CXCR2 dependent/IL-17 independent neutrophil recruitment. Microbes Infect 13:536-44
Abraham, David; Hess, Jessica A; Mejia, Rojelio et al. (2011) Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice. Vaccine 29:8134-40